我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
1
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
2010
终止
100.0%
暂无批准数据
- Basecamp Research has raised $60 million in Series B funding and established a collaboration with the Broad Institute's David Liu lab to develop programmable genetic medicines. - The London-based startup is leveraging its extensive biological interactions database to train AI models, distinguishing itself from traditional AI drug discovery approaches. - The partnership aims to explore novel fusion proteins and large molecules, with potential applications in gene editing by studying bacterial-viral warfare mechanisms.
